In response to COVID-19, the University of Sydney has reviewed the availability of courses to be delivered remotely for students commencing their studies in Semester 1, 2021.
This course will be available to study remotely for students commencing in Semester 1, 2021. Please note that some units of study that are not essential to completing the degree may not be available to be studied remotely.
Note: The University intends to offer as many units of study as possible in a remote as well as face-to-face learning method of delivery in Semester 1, 2021 and subject to ongoing border closures and public health orders impacting attendance on campus, in Semester 2, 2021. However, some units of study and courses require students to study in-person at the relevant University of Sydney campus/es and host locations for placements and will not be available remotely.
About this course
There is a growing need for expertise in modern drug development practices, and the Master of Medicine (Pharmaceutical and Medical Device Development) program provides training in state-of-the-art techniques, approaches, and requirements for the registration of medical products.
This course is designed to introduce students to modern approaches to drug and device design and development, providing an up-to-date set of skills essential for the current industry environment.
100% online course delivery
This course is offered through our interactive online learning environment, giving you the flexibility to tailor your study schedule around your lifestyle.
All stream specific units are online. You may find however; a couple of electives do have a face-to-face component. These can be avoided depending on your individual preferences.
Why study this course?
An industry-focused program, the Master of Medicine (Pharmaceutical and Medical Device Development) has been developed in partnership and is taught by leading minds in the field – in academia, regulatory affairs, intellectual property, regulator and industry bodies and a wide array of reputable industry corporates.
- Learn how to successfully manage the progress of pharmaceuticals and medical devices through crucial regulatory processes
- Bring your own experience and learn from our experts who bring a wealth of experience to this unique program
- Develop expertise in modern drug development practices, from concept to registration and beyond
- Gain invaluable industry experience and connections when you undertake the advanced studies option, which provides the opportunity for an industry placement or research project of your choice
- The fully online delivery is designed for flexibility and to support the learning of busy professionals
Who should study this course?
The program is tailored to professionals working in the pharmaceutical and bio-pharmaceutical industry, regulatory affairs, drug product evaluation, registration, and therapeutic marketing sectors.
It is designed to meet the requirements of those who work or plan to work in different pharmaceutical and medical device development areas. This course would suit graduates of health, pharmacy, medicine, science, engineering, law, business or related disciplines.
Further information:
- Hear Professor Paul Young, discuss the new program in this video.
- Download the course flyer (pdf, 8MB).
Commonwealth Supported Places (CSP) are available for this course for eligible domestic students. This means that your course fees are subsidised by the Australian Government and you pay a student contribution amount (SCA). CSP places are limited in number and are allocated based on academic merit.